Related Experiment Video
Updated: Aug 8, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Screening for chronic hepatitis C: American College of Preventive Medicine practice policy statement
Linda Hill1, Bonnie Henry, Suzanne Schweikert
1University of California-San Diego and San Diego State University, General Preventive Medicine Residency, University of California-San Diego, San Diego, CA, USA.
Insights
Hepatitis C virus (HCV) infection is common, especially in high-risk groups. Expanding screening for these populations is recommended, but universal screening for all adults is not yet supported by evidence.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C is a prevalent, under-diagnosed bloodborne illness.
- Chronic infection can lead to cirrhosis in up to 25% of cases.
- Prevalence in the US is 1.7% overall, but up to 80% in high-risk populations.
Purpose of the Study:
- To summarize the current understanding of Hepatitis C virus (HCV) epidemiology.
- To evaluate the effectiveness and recommendations for screening and treatment.
Main Methods:
- Literature review of HCV prevalence, transmission, and treatment efficacy.
- Analysis of screening value in different population groups.
Main Results:
- HCV transmission is understood, but prevention is hindered by socioeconomic and political factors.
- Antiviral treatments have variable efficacy (40-85%) and high cost.
- Screening high-risk populations is valuable and should be expanded.
Conclusions:
- While screening high-risk populations for Hepatitis C is beneficial, universal screening for all adults lacks sufficient evidence.
- Further research may be needed to address economic, social, and political barriers to prevention and treatment.
Abstract:
Hepatitis C is an under-diagnosed and prevalent bloodborne illness, resulting in chronic cirrhosis in up to 25% of those infected. While the overall prevalence in the United States is 1.7%, high-risk populations may have up to 80% prevalence. The mechanism of transmission is well understood, but effective preventive measures are hampered by economic, social, and political factors. Antiviral treatment is expensive, and efficacy ranges from 40% to 85%. The value of screening high-risk populations has been demonstrated, and should be expanded; however, there is insufficient evidence to recommend universal screening for adults.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Preventive Healthcare Services
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Hepatitis
Viral Hepatitis I: Introduction